Jinshi Asia Pharmaceutical (300434.SZ) released its first three quarters performance, with net profit attributable to the parent company of 142 million yuan, a year-on-year increase of 46.33%.

Zhitong Finance APP News, Jinshi Yayao (300434.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 711 million yuan, a year-on-year increase of 0.30%. Net profit attributable to shareholders of the listed company was 142 million yuan, a year-on-year increase of 46.33%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 129 million yuan, a year-on-year increase of 63.57%.